Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...

About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...

Millions of Americans are born predisposed to high levels of a cholesterol called lipoprotein(a). Doctors are finally ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

An estimated 64 million Americans have elevated levels of lipoprotein(a), or Lp(a), a type of cholesterol that can increase the risk of heart attack and other cardiovascular problems. Having high ...

A new study published in the recent issue of Atherosclerosis journal showed that lipoprotein(a) [Lp(a)] levels may change the ...

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

A study published in the British Medical Journal investigated the relationship between baseline low-density lipoprotein cholesterol (LDL-C) levels and the | Immunology ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...